Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 36.8
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Solid dividends
Data is available to registered users only
Data is available to registered users only
About
TCI GENE Inc. provides precision preventive medicines in Taiwan. It offers genetic testing for nutrient metabolism and weight management; G2 and ACE2 genetic testing; supplements; skin care, antiaging, kids' growth, and Alzheimer disease products; and serum for DNA types. The company also provides nutrition consultation services. TCI GENE Inc. is based in Taipei, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o
Data is available to registered users only
